TGFB1 and central nervous system cancer: These data suggest that miR-210-3p exerts its malignancy-promoting effects in glioma cells via a mechanism mainly dependent on TGF-β expression, which is consistent with the previous report showing that miR-210-3p exerts as a promoter of malignancies in glioma [36].